KarstoftK, WindingK, KnudsenSH, et al. Mechanisms behind the superior effects of interval vs continuous training on glycaemic control in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia, 2014; 57: 2081–2093.
2.
MadsenSM, ThorupAC, OvergaardK, et al. High intensity interval training improves glycaemic control and pancreatic β cell function of type 2 diabetes patients. PloS One, 2015; 10: e0133286.
3.
DelaF, von LinstowME, MikinesKJ, et al. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab, 2004; 287: E1024–1031.
4.
García-GarcíaF, KumareswaranK, HovorkaR, et al. Quantifying the acute changes in glucose with exercise in type 1 diabetes: a systematic review and meta-analysis. Sports Med Auckl NZ, 2015; 45: 587–599.
5.
BergfordS, RiddellMC, JacobsPG, et al. The Type 1 Diabetes and EXercise Initiative: predicting hypoglycemia risk during exercise for participants with type 1 diabetes using repeated measures random forest. Diabetes Technol Ther, 2023; 25: 602–611.
6.
SteineckIIK, RanjanA, SchmidtS, et al. Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study. Diabetologia, 2019; 62: 582–592.
7.
MoserO, RiddellMC, EcksteinML, et al. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia, 2020; 63: 2501–2520.
8.
WallaceAS, ChangAR, ShinJ-I, et al. Obesity and chronic kidney disease in US adults with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab, 2022; 107: 1247–1256.
9.
IgudesmanD, CrandellJ, CorbinKD, et al. Weight management in young adults with type 1 diabetes: the advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results. Diabetes Obes Metab, 2023; 25: 688–699.
10.
MuntisFR, IgudesmanD, SarteauAC, et al. Relationship between moderate-to-vigorous physical activity and glycemia among young adults with type 1 diabetes and overweight or obesity: results from the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study. Diabetes Technol Ther, 2022; 24: 881–891.
11.
RiddellMC, LiZ, BeckRW, et al. More time in glucose range during exercise days than sedentary days in adults living with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 376–383.
12.
GalJJ, LiZ, WilliSM, et al. Association between high levels of physical activity and improved glucose control on active days in youth with type 1 diabetes. Pediatr Diabetes, 2022; 23: 1057–1063.
13.
RavussinE, BeylRA, PoggiogalleE, et al. Early time-restricted feeding reduces appetite and increases fat oxidation but does not affect energy expenditure in humans. Obesity, 2019; 27: 1244–1254.
14.
JamshedH, BeylRA, Della MannaDL, et al. Early time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans. Nutrients, 2019; 11: 1234.
15.
SuttonEF, BeylR, EarlyKS, et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab, 2018; 27: 1212–1221.
16.
GabelK, HoddyKK, HaggertyN, et al. Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: a pilot study. Nutr Healthy Aging, 2018; 4: 345–353.
17.
EizirikDL, PasqualiL, CnopM. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol, 2020; 16: 349–362.
18.
EizirikDL, SzymczakF, AlvelosMI, et al. From pancreatic β-cell gene networks to novel therapies for type 1 diabetes. Diabetes, 2021; 70: 1915–1925.
19.
GitelmanSE, BundyBN, FerranniniE, et al. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol, 2021; 9: 502–514.
20.
ColbergSR, SigalRJ, YardleyJE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care, 2016; 39: 2065–2079.
21.
JebeileH, GowML, ListerNB, et al. Intermittent energy restriction is a feasible, effective, and acceptable intervention to treat adolescents with obesity. J Nutr, 2019; 149: 1189–1197.
22.
WangX, LiQ, LiuY, et al. Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract, 2021; 179: 109003.
23.
Van den BurgEL, van PeetPG, SchoonakkerMP, et al. Metabolic impact of intermittent energy restriction and periodic fasting in patients with type 2 diabetes: a systematic review. Nutr Rev, 2023; 81: 1329–1350.
24.
Mosquera-LopezC, RamseyKL, Roquemen-EcheverriV, et al. Modeling risk of hypoglycemia during and following physical activity in people with type 1 diabetes using explainable mixed-effects machine learning. Comput Biol Med, 2023; 155: 106670.
25.
CutovicM, KonstantinovicL, StankovicZ, et al. Structured exercise program improves functional capacity and delays relapse in euthyroid patients with Graves' disease. Disabil Rehabil, 2012; 34: 1511–1518.
26.
NaldiL, ContiA, CazzanigaS, et al. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol, 2014; 170: 634–642.
27.
Coomans de BrachèneA, ScoubeauC, MusuayaAE, et al. Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes. Diabetologia, 2023; 66: 450–460.